{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T01:57:22Z","timestamp":1794535042716,"version":"4.9.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T00:00:00Z","timestamp":1588636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T00:00:00Z","timestamp":1588636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01ZX1909A"],"award-info":[{"award-number":["01ZX1909A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01EW1908"],"award-info":[{"award-number":["01EW1908"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01ZX1909A"],"award-info":[{"award-number":["01ZX1909A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["402170461 \u2013 TRR 265"],"award-info":[{"award-number":["402170461 \u2013 TRR 265"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["402170461 \u2013 TRR 265"],"award-info":[{"award-number":["402170461 \u2013 TRR 265"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1038\/s41386-020-0694-z","type":"journal-article","created":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T08:02:26Z","timestamp":1588665746000},"page":"1316-1322","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Psilocybin and LSD have no long-lasting effects in an animal model of alcohol relapse"],"prefix":"10.1038","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5103-0731","authenticated-orcid":false,"given":"Marcus W.","family":"Meinhardt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cansu","family":"G\u00fcng\u00f6r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6749-9745","authenticated-orcid":false,"given":"Ivan","family":"Skorodumov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea J.","family":"Mertens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Spanagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,5]]},"reference":[{"key":"694_CR1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1126\/science.345.6192.18","volume":"345","author":"K Kupferschmidt","year":"2014","unstructured":"Kupferschmidt K. High hopes. Science. 2014;345:18\u201323.","journal-title":"Science."},{"key":"694_CR2","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.neubiorev.2019.12.001","volume":"108","author":"RG dos Santos","year":"2020","unstructured":"dos Santos RG, Hallak JEC. Therapeutic use of serotoninergic hallucinogens: a review of the evidence and of the biological and psychological mechanisms. Neurosci Biobehav Rev. 2020;108:423\u201334.","journal-title":"Neurosci Biobehav Rev"},{"key":"694_CR3","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1038\/npp.2017.86","volume":"42","author":"ME Liechti","year":"2017","unstructured":"Liechti ME. Modern clinical research on LSD. Neuropsychopharmacology 2017;42:2114\u201327.","journal-title":"Neuropsychopharmacology"},{"key":"694_CR4","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1038\/npp.2017.84","volume":"42","author":"RL Carhart-Harris","year":"2017","unstructured":"Carhart-Harris RL, Goodwin GM. The therapeutic potential of psychedelic drugs: past, present, and future. Neuropsychopharmacology 2017;42:2105\u201313.","journal-title":"Neuropsychopharmacology"},{"key":"694_CR5","doi-asserted-by":"publisher","unstructured":"Hibicke M, Landry AN, Kramer HM, Talman ZK, Nichols CD. Psychedelics, but not ketamine, produce persistent antidepressant-like effects in a rodent experimental system for the study of depression. ACS Appl Mater Interfaces. 2020. https:\/\/doi.org\/10.1021\/acschemneuro.9b00493.","DOI":"10.1021\/acschemneuro.9b00493"},{"key":"694_CR6","doi-asserted-by":"crossref","first-page":"e0211023","DOI":"10.1371\/journal.pone.0211023","volume":"14","author":"V Polito","year":"2019","unstructured":"Polito V, Stevenson RJ. A systematic study of microdosing psychedelics. PLoS ONE. 2019;14:e0211023.","journal-title":"PLoS ONE"},{"key":"694_CR7","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s00213-018-5106-2","volume":"236","author":"T Anderson","year":"2019","unstructured":"Anderson T, Petranker R, Rosenbaum D, Weissman CR, Dinh-Williams LA, Hui K, et al. Microdosing psychedelics: personality, mental health, and creativity differences in microdosers. Psychopharmacology. 2019;236:731\u201340.","journal-title":"Psychopharmacology."},{"key":"694_CR8","doi-asserted-by":"publisher","unstructured":"Rosenbaum D, Weissman C, Anderson T, Petranker R, Dinh-Williams LA, Hui K, et al. Microdosing psychedelics: demographics, practices, and psychiatric comorbidities. J Psychopharmacol. 2020:269881120908004. https:\/\/doi.org\/10.1177\/0269881120908004 [Epub ahead of print].","DOI":"10.1177\/0269881120908004"},{"key":"694_CR9","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1001\/jamapsychiatry.2017.2161","volume":"74","author":"BF Grant","year":"2017","unstructured":"Grant BF, Chou SP, Saha TD, Pickering RP, Kerridge BT, Ruan WJ, et al. Prevalence of 12-month alcohol use, high-risk drinking, and DSM-IV alcohol use disorder in the United States, 2001\u20132 to 2012\u20133: results from the National Epidemiologic Survey on Alcohol and Related Conditions. JAMA Psychiatry. 2017;74:911\u201323.","journal-title":"JAMA Psychiatry."},{"key":"694_CR10","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/S0140-6736(09)60746-7","volume":"373","author":"J Rehm","year":"2009","unstructured":"Rehm J, Mathers C, Popova S, Thavorncharoensap M, Teerawattananon Y, Patra J. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet. 2009;373:2223\u201333.","journal-title":"Lancet."},{"key":"694_CR11","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/978-3-642-28720-6_205","volume":"13","author":"R Spanagel","year":"2012","unstructured":"Spanagel R, Vengeliene V. New pharmacological treatment strategies for relapse prevention. Curr Top Behav Neurosci. 2012;13:583\u2013609.","journal-title":"Curr Top Behav Neurosci."},{"key":"694_CR12","doi-asserted-by":"crossref","unstructured":"Fertig J, Leggio L, Litten RZ, Falk DE, Ryan ML. Advances in pharmacotherapy development: human clinical studies. Handbook of experimental pharmacology. Springer Nature, Switzerland. 2018;248:579\u2013613.","DOI":"10.1007\/164_2017_79"},{"key":"694_CR13","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/adb.12349","volume":"22","author":"MM Yardley","year":"2017","unstructured":"Yardley MM, Ray LA. Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models. Addict Biol. 2017;22:581\u2013615.","journal-title":"Addict Biol."},{"key":"694_CR14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2174\/15733998113099990002","volume":"6","author":"MP Bogenschutz","year":"2013","unstructured":"Bogenschutz MP. Studying the effects of classic hallucinogens in the treatment of alcoholism: rationale, methodology, and current research with psilocybin. Curr Drug Abus Rev. 2013;6:17\u201329.","journal-title":"Curr Drug Abus Rev"},{"key":"694_CR15","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.neuropharm.2017.12.040","volume":"142","author":"JJH Rucker","year":"2018","unstructured":"Rucker JJH, Iliff J, Nutt DJ. Psychiatry & the psychedelic drugs. Past, present & future. Neuropharmacology. 2018;142:200\u201318.","journal-title":"Neuropharmacology."},{"key":"694_CR16","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1177\/0269881112439253","volume":"26","author":"TS Krebs","year":"2012","unstructured":"Krebs TS, Johansen P\u00d8r. Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials. J Psychopharmacol. 2012;26:994\u20131002.","journal-title":"J Psychopharmacol."},{"key":"694_CR17","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/0269881114565144","volume":"29","author":"MP Bogenschutz","year":"2015","unstructured":"Bogenschutz MP, Forcehimes AA, Pommy JA, Wilcox CE, Barbosa P, Strassman RJ. Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study. J Psychopharmacol. 2015;29:289\u201399.","journal-title":"J Psychopharmacol."},{"key":"694_CR18","doi-asserted-by":"crossref","first-page":"247","DOI":"10.31887\/DCNS.2017.19.3\/rspanagel","volume":"19","author":"R Spanagel","year":"2017","unstructured":"Spanagel R. Animal models of addiction. Dialogues Clin Neurosci. 2017;19:247\u201358.","journal-title":"Dialogues Clin Neurosci"},{"key":"694_CR19","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.alcohol.2014.03.002","volume":"48","author":"V Vengeliene","year":"2014","unstructured":"Vengeliene V, Bilbao A, Spanagel R. The alcohol deprivation effect model for studying relapse behavior: a comparison between rats and mice. Alcohol. 2014;48:313\u201320.","journal-title":"Alcohol."},{"key":"694_CR20","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1369-1600.2009.00177.x","volume":"14","author":"V Vengeliene","year":"2009","unstructured":"Vengeliene V, Celerier E, Chaskiel L, Penzo F, Spanagel R. Compulsive alcohol drinking in rodents. Addict Biol. 2009;14:384\u201396.","journal-title":"Addict Biol"},{"key":"694_CR21","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s002130051069","volume":"145","author":"SM H\u00f6lter","year":"1999","unstructured":"H\u00f6lter SM, Spanagel R. Effects of opiate antagonist treatment on the alcohol deprivation effect in long-term ethanol-experienced rats. Psychopharmacology. 1999;145:360\u20139.","journal-title":"Psychopharmacology"},{"key":"694_CR22","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0014-2999(96)00174-4","volume":"305","author":"R Spanagel","year":"1996","unstructured":"Spanagel R, H\u00f6lter SM, Allingham K, Landgraf R, Zieglg\u00e4nsberger W. Acamprosate and alcohol: I. Effects on alcohol intake following alcohol deprivation in the rat. Eur J Pharm. 1996;305:39\u201344.","journal-title":"Eur J Pharm"},{"key":"694_CR23","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s00213-006-0457-5","volume":"187","author":"RR Griffiths","year":"2006","unstructured":"Griffiths RR, Richards WA, McCann U, Jesse R. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology. 2006;187:268\u201383.","journal-title":"Psychopharmacology"},{"key":"694_CR24","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00213-011-2358-5","volume":"218","author":"RR Griffiths","year":"2011","unstructured":"Griffiths RR, Johnson MW, Richards WA, Richards BD, McCann U, Jesse R. Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects. Psychopharmacology. 2011;218:649\u201365.","journal-title":"Psychopharmacology"},{"key":"694_CR25","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1021\/acschemneuro.8b00134","volume":"9","author":"LP Cameron","year":"2018","unstructured":"Cameron LP, Benson CJ, Dunlap LE, Olson DE. Effects of N, N-dimethyltryptamine on rat behaviors relevant to anxiety and depression. ACS Chem Neurosci. 2018;9:1582\u201390.","journal-title":"ACS Chem Neurosci"},{"key":"694_CR26","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","volume":"23","author":"C Ly","year":"2018","unstructured":"Ly C, Greb AC, Cameron LP, Wong JM, Barragan EV, Wilson PC, et al. Psychedelics promote structural and functional neural plasticity. Cell Rep. 2018;23:3170\u201382.","journal-title":"Cell Rep."},{"key":"694_CR27","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.biopsych.2010.05.029","volume":"68","author":"V Vengeliene","year":"2010","unstructured":"Vengeliene V, Leonardi-Essmann F, Sommer WH, Marston HM, Spanagel R. Glycine transporter-1 blockade leads to persistently reduced relapse-like alcohol drinking in rats. Biol Psychiatry. 2010;68:704\u201311.","journal-title":"Biol Psychiatry."},{"key":"694_CR28","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/adb.12675","volume":"24","author":"F Ezquer","year":"2018","unstructured":"Ezquer F, Quintanilla ME, Morales P, Santapau D, Ezquer M, Kogan MJ, et al. Intranasal delivery of mesenchymal stem cell-derived exosomes reduces oxidative stress and markedly inhibits ethanol consumption and post-deprivation relapse drinking. Addict Biol. 2018;24:994\u20131007.","journal-title":"Addict Biol."},{"key":"694_CR29","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/adb.12382","volume":"21","author":"C Sanchis-Segura","year":"2016","unstructured":"Sanchis-Segura C, Becker JB. Why we should consider sex (and study sex differences) in addiction research. Addict Biol. 2016;21:995\u20131006.","journal-title":"Addict Biol."},{"key":"694_CR30","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.neuropharm.2005.01.002","volume":"48","author":"V Vengeliene","year":"2005","unstructured":"Vengeliene V, Bachteler D, Danysz W, Spanagel R. The role of the NMDA receptor in alcohol relapse: a pharmacological mapping study using the alcohol deprivation effect. Neuropharmacology. 2005;48:822\u20139.","journal-title":"Neuropharmacology."},{"key":"694_CR31","first-page":"41","volume":"9","author":"SM H\u00f6lter","year":"1998","unstructured":"H\u00f6lter SM, Engelmann M, Kirschke C, Liebsch G, Landgraf R, Spanagel R. Long-term ethanol self-administration with repeated ethanol deprivation episodes changes ethanol drinking pattern and increases anxiety-related behaviour during ethanol deprivation in rats. Behav Pharmacol. 1998;9:41\u201348.","journal-title":"Behav Pharmacol."},{"key":"694_CR32","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s002130000601","volume":"153","author":"SM H\u00f6lter","year":"2000","unstructured":"H\u00f6lter SM, Henniger MSH, Lipkowski AW, Spanagel R. Kappa-opioid receptors and relapse-like drinking in long-term ethanol-experienced rats. Psychopharmacology. 2000;153:93\u2013102.","journal-title":"Psychopharmacology"},{"key":"694_CR33","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/npp.2015.225","volume":"41","author":"V Vengeliene","year":"2016","unstructured":"Vengeliene V, Moeller A, Meinhardt MW, Beardsley PM, Sommer WH, Spanagel R, et al. The calpain inhibitor A-705253 attenuates alcohol-seeking and relapse with low side-effect profile. Neuropsychopharmacology. 2016;41:979\u201388.","journal-title":"Neuropsychopharmacology."},{"key":"694_CR34","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1021\/acschemneuro.8b00692","volume":"10","author":"LP Cameron","year":"2019","unstructured":"Cameron LP, Benson CJ, Defelice BC, Fiehn O, Olson DE. Chronic, intermittent microdoses of the psychedelic N, N-dimethyltryptamine (DMT) produce positive effects on mood and anxiety in rodents. ACS Chem Neurosci. 2019;10:3261\u201370.","journal-title":"ACS Chem Neurosci"},{"key":"694_CR35","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0091-3057(77)90180-0","volume":"6","author":"M Davis","year":"1977","unstructured":"Davis M, Walters JK. Psilocybin: Biphasic dose-response effects on the acoustic startle reflex in the rat. Pharm Biochem Behav. 1977;6:427\u201331.","journal-title":"Pharm Biochem Behav"},{"key":"694_CR36","doi-asserted-by":"publisher","unstructured":"Jefsen O, H\u00f8jgaard K, Christiansen SL, Elfving B, Nutt DJ, Wegener G, et al. Psilocybin lacks antidepressant-like effect in the Flinders Sensitive Line rat. Acta Neuropsychiatr. 2019. https:\/\/doi.org\/10.1017\/neu.2019.15.","DOI":"10.1017\/neu.2019.15"},{"key":"694_CR37","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/BF00435266","volume":"76","author":"J Koerner","year":"1982","unstructured":"Koerner J, Appel JB. Psilocybin as a discriminative stimulus: lack of specificity in an animal behavior model for \u2018hallucinogens\u2019. Psychopharmacology. 1982;76:130\u20135.","journal-title":"Psychopharmacology"},{"key":"694_CR38","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/1455072517753339","volume":"35","author":"PG Johnstad","year":"2018","unstructured":"Johnstad PG. Powerful substances in tiny amounts: an interview study of psychedelic microdosing. NAD Nord Stud Alcohol Drugs. 2018;35:39\u201351.","journal-title":"NAD Nord Stud Alcohol Drugs"},{"key":"694_CR39","doi-asserted-by":"crossref","first-page":"994","DOI":"10.3389\/fphar.2018.00994","volume":"9","author":"K Alper","year":"2018","unstructured":"Alper K, Dong B, Shah R, Sershen H, Vinod KY. LSD administered as a single dose reduces alcohol consumption in C57BL\/6J mice. Front Pharmacol. 2018;9:994.","journal-title":"Front Pharmacol."},{"key":"694_CR40","doi-asserted-by":"publisher","unstructured":"Lea T, Amada N, Jungaberle H. Psychedelic microdosing: a subreddit analysis. J Psychoactive Drugs. 2019. https:\/\/doi.org\/10.1080\/02791072.2019.1683260.","DOI":"10.1080\/02791072.2019.1683260"},{"key":"694_CR41","doi-asserted-by":"crossref","first-page":"102600","DOI":"10.1016\/j.drugpo.2019.11.008","volume":"75","author":"T Lea","year":"2020","unstructured":"Lea T, Amada N, Jungaberle H, Schecke H, Klein M. Microdosing psychedelics: motivations, subjective effects and harm reduction. Int J Drug Policy. 2020;75:102600.","journal-title":"Int J Drug Policy."},{"key":"694_CR42","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/FBP.0000000000000394","volume":"29","author":"RR Horsley","year":"2018","unstructured":"Horsley RR, P\u00e1len\u00edcek T, Kolin J, Vale\u0161 K. Psilocin and ketamine microdosing: effects of subchronic intermittent microdoses in the elevated plus-maze in male Wistar rats. Behav Pharmacol. 2018;29:530\u20136.","journal-title":"Behav Pharmacol."},{"key":"694_CR43","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1152\/physrev.00013.2008","volume":"89","author":"R Spanagel","year":"2009","unstructured":"Spanagel R. Alcoholism: a systems approach from molecular physiology to addictive behavior. Physiol Rev. 2009;89:649\u2013705.","journal-title":"Physiol Rev."},{"key":"694_CR44","doi-asserted-by":"crossref","first-page":"9917","DOI":"10.1523\/JNEUROSCI.21-24-09917.2001","volume":"21","author":"P Celada","year":"2001","unstructured":"Celada P, Victoria Puig M, Casanovas JM, Guillazo G, Artigas F. Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex: involvement of serotonin-1A, GABAA, and glutamate receptors. J Neurosci. 2001;21:9917\u201329.","journal-title":"J Neurosci."},{"key":"694_CR45","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/cercor\/13.8.870","volume":"13","author":"MV Puig","year":"2003","unstructured":"Puig MV, Celada P, D\u00edaz-Mataix L, Artigas F. In vivo modulation of the activity of pyramidal neurons in the rat medial prefrontal cortex by 5-HT2A receptors: relationship to thalamocortical afferents. Cereb Cortex. 2003;13:870\u201382.","journal-title":"Cereb Cortex."},{"key":"694_CR46","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1093\/cercor\/bhn204","volume":"19","author":"P V\u00e1zquez-Borsetti","year":"2009","unstructured":"V\u00e1zquez-Borsetti P, Cort\u00e9s R, Artigas F. Pyramidal neurons in rat prefrontal cortex projecting to ventral tegmental area and dorsal raphe nucleus express 5-HT2A receptors. Cereb Cortex. 2009;19:1678\u201386.","journal-title":"Cereb Cortex."},{"key":"694_CR47","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0893-133X(98)00108-0","volume":"20","author":"FX Vollenweider","year":"1999","unstructured":"Vollenweider FX, Vontobel P, Hell D, Leenders KL. 5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in Man\u2014a PET study with [11C] raclopride. Neuropsychopharmacology. 1999;20:424\u201333.","journal-title":"Neuropsychopharmacology."},{"key":"694_CR48","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.neuron.2007.01.008","volume":"53","author":"J Gonz\u00e1lez-Maeso","year":"2007","unstructured":"Gonz\u00e1lez-Maeso J, Weisstaub NV, Zhou M, Chan P, Ivic L, Ang R, et al. Hallucinogens recruit specific cortical 5-HT2A receptor-mediated signaling pathways to affect behavior. Neuron. 2007;53:439\u201352.","journal-title":"Neuron."},{"key":"694_CR49","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/neuro.08.006.2007","volume":"1","author":"R Poirier","year":"2007","unstructured":"Poirier R, Cheval H, Mailhes C, Charnay P, Davis S, Laroche S. Paradoxical role of an Egr transcription factor family member, Egr2\/Krox20, in learning and memory. Front Behav Neurosci. 2007;1:6.","journal-title":"Front Behav Neurosci"},{"key":"694_CR50","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1523\/JNEUROSCI.4062-12.2013","volume":"33","author":"MW Meinhardt","year":"2013","unstructured":"Meinhardt MW, Hansson AC, Perreau-Lenz S, Bauder-Wenz C, St\u00e4hlin O, Heilig M, et al. Rescue of infralimbic mGluR2 deficit restores control over drug-seeking behavior in alcohol dependence. J Neurosci. 2013;33:2794\u2013806.","journal-title":"J Neurosci."},{"key":"694_CR51","doi-asserted-by":"crossref","first-page":"469","DOI":"10.15288\/qjsa.1966.27.469","volume":"27","author":"RG Smart","year":"1966","unstructured":"Smart RG, Storm T, Baker EF, Solursh L. A controlled study of lysergide in the treatment of alcoholism. 1. The effects on drinking behavior. Q J Stud Alcohol. 1966;27:469\u201382.","journal-title":"Q J Stud Alcohol"},{"key":"694_CR52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/adb.12187","volume":"20","author":"MW Meinhardt","year":"2015","unstructured":"Meinhardt MW, Sommer WH. Postdependent state in rats as a model for medication development in alcoholism. Addict Biol. 2015;20:1\u201321.","journal-title":"Addict Biol."},{"key":"694_CR53","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1369-1600.2005.00029.x","volume":"11","author":"RL Bell","year":"2006","unstructured":"Bell RL, Rodd ZA, Lumeng L, Murphy JM, McBride WJ. The alcohol-preferring P rat and animal models of excessive alcohol drinking. Addict Biol. 2006;11:270\u201388.","journal-title":"Addict Biol."},{"key":"694_CR54","doi-asserted-by":"crossref","first-page":"e12866","DOI":"10.1111\/adb.12866","volume":"25","author":"A Heinz","year":"2020","unstructured":"Heinz A, Kiefer F, Smolka MN, Endrass T, Beste C, Beck A, et al. Addiction Research Consortium: Losing and regaining control over drug intake (ReCoDe)\u2014from trajectories to mechanisms and interventions. Addict Biol. 2020;25:e12866.","journal-title":"Addict Biol."}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41386-020-0694-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41386-020-0694-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41386-020-0694-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T14:20:38Z","timestamp":1696083638000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-020-0694-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,5]]},"references-count":54,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["694"],"URL":"https:\/\/doi.org\/10.1038\/s41386-020-0694-z","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,5]]},"assertion":[{"value":"10 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}